Streamex Corp.
STEXNasdaq
$0.78
↑ +5.6%Jul 17 close · end-of-day
Price
1Y↓ -85.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$136.7M
Enterprise Value
$129.9M
P/E
—
P/S
—
P/B
0.9
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$506.7M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-318.7%
ROIC
-53.9%
Debt / Equity
—
Net Cash
$6.9M
Return 1Y
-83.5%
Company profile
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system. PURE EP is a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition.
- CEO
- Kenneth L. Londoner
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 50
- Headquarters
- Connecticut
- Website
- biosig.com
Earnings
STEX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$0.27↑ +92.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $441,000.00 | $286,000.00 | $18,000.00 | $40,000.00 | — |
| Gross profit | $0.00 | $242,000.00 | $229,000.00 | $18,000.00 | — | — |
| Operating income | -$59.2M | -$33.4M | -$27.3M | -$28.5M | -$12.9M | -$71.1M |
| Net income | -$52.2M | -$31.9M | -$27.1M | -$29.0M | -$10.3M | -$462.8M |
| Diluted EPS | — | — | -$6.33 | -$3.95 | -$0.75 | -$9.65 |
| Operating cash flow | -$26.6M | -$26.4M | -$21.7M | -$17.3M | -$4.8M | -$10.4M |
| Free cash flow | -$26.7M | -$26.9M | -$21.9M | -$17.5M | — | — |
| Gross margin | — | 54.9% | 80.1% | 100.0% | — | — |
| Operating margin | — | -7576.2% | -9533.2% | -158400.0% | -32155.0% | — |
| Net margin | — | -7237.4% | -9458.7% | -161338.9% | -25825.0% | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13,000.00 | $0.00 | $13,000.00 | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$5.3M | -$3.0M | -$1.2M | -$3.0M | -$20.4M | -$6.1M | -$41.6M | -$35.7M |
| Net income | -$3.9M | -$1.9M | -$1.1M | -$2.8M | -$20.4M | -$15.6M | -$424.0M | -$46.7M |
| Diluted EPS | -$0.30 | -$0.12 | $0.03 | -$0.14 | -$0.74 | -$0.47 | -$8.30 | -$0.27 |
| Operating cash flow | -$1.5M | -$1.5M | -$474,000.00 | -$1.1M | -$1.3M | -$5.0M | -$3.0M | -$10.2M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -40707.7% | — | -9100.0% | — | — | — | — | — |
| Net margin | -30115.4% | — | -8453.8% | — | — | — | — | — |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.